Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-04-21
1996-07-30
Robinson, Allen J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 31415
Patent
active
055412122
ABSTRACT:
The invention relates to histamine H2-receptor antagonists such as cimetidine and related compounds such as ranitidine and famotidine that can be used for controlling human immunodeficiency virus (HIV) infection. The preferred agent is cimetidine. The invention comprises a method in vitro as well as in vivo for controlling, i.e., prevention and/or treatment, of HIV infection, associated with the development of acquired immune deficiency syndrome (AIDS), at pharmacological doses of these drugs commonly used for the treatment of gastrointestinal ulcers. The method is based on inhibiting HIV in vitro or on the administration to a host that has been exposed to HIV prior to diagnosis or has been diagnosed as having an HIV infection, of an amount of a H2 antagonist which is sufficient to exert an anti-HIV effect for a sufficient period of time.
REFERENCES:
patent: 5102902 (1992-04-01), Mercer
patent: 5286852 (1994-02-01), Osther
J. Virological Methods, 35, pp. 49-58 (1991).
Immunol. & Infec. Dis., 2, 245-247 (1992).
FEBS Lett., vol. 302, No. 3, 206-208 1992.
E. J. of Pharmacol, 230, (1993) 15-22.
FEBS Lett., vol. 309, No. 1, 82-84 (1992).
Science, vol. 259, 1749-1754 (1993).
J. Inf. Diseases, 167, 1498-9 (1993).
J. of Virology, 67, 2182-2190 (1993).
Science, 229 563-566 (1985).
Science, 260, 1286-1293 (1993).
Virology, 189, 695-714 (1992).
Acta, Virol, 37:241-250 (1993).
Viral Quantitation in HIV Infection, J. M. Andriew, Ed. John Libbey, pp. 41-52 (1992).
Aids Res. & Human Retroviruses, vol. 8, No. 9, p. 1545 (1992).
Clin. Immol, Immunopath. 48, 50-60 (1988).
J. Nat. Cancer Inst., vol. 83, No. 2, 139-141 (1991).
J. Acq. Immuno. Def. Syndromes, vol. 4, No. 6, 577-584 (1991).
Cebulak Mary C.
Metatron, Inc.
Robinson Allen J.
LandOfFree
Use of cimetidine for the control of retrovirus infections does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of cimetidine for the control of retrovirus infections, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of cimetidine for the control of retrovirus infections will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1659003